Epstein-Barr Virus (EBV), stained with Hematoxylin and eosin (H&E)
Epstein-Barr Virus (EBV), stained with Hematoxylin and eosin (H&E)

Image source: National Cancer Institute

News • Corona and EBV

Long Covid symptoms likely caused by Epstein-Barr virus reactivation

Epstein-Barr virus (EBV) reactivation resulting from the inflammatory response to coronavirus infection may be the cause of previously unexplained long Covid symptoms—such as fatigue, brain fog, and rashes—that occur in approximately 30% of patients after recovery from initial Covid-19 infection.

The first evidence linking EBV reactivation to long Covid, as well as an analysis of long Covid prevalence, is outlined in a new long Covid study published in the journal Pathogens. "We ran EBV antibody tests on recovered Covid-19 patients, comparing EBV reactivation rates of those with long Covid symptoms to those without long Covid symptoms," said lead study author Jeffrey E. Gold of World Organization. "The majority of those with long Covid symptoms were positive for EBV reactivation, yet only 10% of controls indicated reactivation."

Recommended article

Photo

Article • Post-hospitalisation

New study reveals impact of 'Long Covid'

Recovery duration, co-morbidities, mortality, risk groups: A large UK study reports in detail on 'Long Covid'. We spoke with two of the study's co-investigators about why so many patients are still affected after a coronavirus infection.

The researchers began by surveying 185 randomly selected patients recovered from Covid-19 and found that 30.3% had long term symptoms consistent with long Covid after initial recovery from SARS-CoV-2 infection. This included several patients with initially asymptomatic Covid-19 cases who later went on to develop long Covid symptoms. The researchers then found, in a subset of 68 Covid-19 patients randomly selected from those surveyed, that 66.7% of long Covid subjects versus 10% of controls were positive for EBV reactivation based on positive EBV early antigen-diffuse (EA-D) IgG or EBV viral capsid antigen (VCA) IgM titers. The difference was significant (p < 0.001, Fisher's exact test). "We found similar rates of EBV reactivation in those who had long Covid symptoms for months, as in those with long Covid symptoms that began just weeks after testing positive for Covid-19," said coauthor David J. Hurley, Ph.D., a professor and molecular microbiologist at the University of Georgia. "This indicated to us that EBV reactivation likely occurs simultaneously or soon after Covid-19 infection."

Photo
Skin manifestations of six long Covid subjects positive for EBV reactivation (two photos of each subject)

Image source: Gold et al., Pathogens 2021 (CC BY 4.0)

The relationship between SARS-CoV-2 and EBV reactivation described in this study opens up new possibilities for long Covid diagnosis and treatment. The researchers indicated that it may be prudent to test patients newly positive for Covid-19 for evidence of EBV reactivation indicated by positive EBV EA-D IgG, EBV VCA IgM, or serum EBV DNA tests. If patients show signs of EBV reactivation, they can be treated early to reduce the intensity and duration of EBV replication, which may help inhibit the development of long Covid.

"As evidence mounts supporting a role for EBV reactivation in the clinical manifestation of acute Covid-19, this study further implicates EBV in the development of long Covid," said Lawrence S. Young, Ph.D., a virologist at the University of Warwick, and Editor-in-Chief of Pathogens. "If a direct role for EBV reactivation in long Covid is supported by further studies, this would provide opportunities to improve the rational diagnosis of this condition and to consider the therapeutic value of anti-herpesvirus agents such as ganciclovir." 


Source: World Organization                                                                                              

24.06.2021

Read all latest stories

Related articles

Photo

News • Unifying disease dynamics

Covid-19: New insights into recovery after severe disease

Recovery from severe Covid-19 is characterized by a reduction of certain white blood cells and changes in the molecular regulation of the immune system, an international research team found.

Photo

News • Protein malformation

Covid-19: immune reaction may cause amyloid generation

In patients with serious and long-term Covid-19, disturbed blood coagulation is often observed. Now, Swedish researchers found a connection between harmful amyloid production and Covid-19 symptoms.

Photo

News • UV sterilization

Ultraviolet disinfection against Covid-19: Study gives new insights

UV radiation is one of the go-to methods for preventing the spread of SARS-CoV-2. But what UV dosage kills the virus? What wavelength? How long? A new study answers many of those questions.

Related products

Sarstedt - COVID-19 virus diagnostics products

Saliva Collection

Sarstedt - COVID-19 virus diagnostics products

SARSTEDT AG & CO. KG
Zybio – Disposable Virus Sampling Tube

Sample Collection

Zybio – Disposable Virus Sampling Tube

Zybio Inc.
Beckman Coulter – SARS-CoV-2 Assays

Immunoassays

Beckman Coulter – SARS-CoV-2 Assays

Beckman Coulter Diagnostics
Lifotronic  SARS-CoV-2 Antibody Detection Kit

Immunoassays

Lifotronic SARS-CoV-2 Antibody Detection Kit

Lifotronic Technology Co., Ltd
Lifotronic – SARS-CoV-2 Antigen

Immunoassays

Lifotronic – SARS-CoV-2 Antigen

Lifotronic Technology Co., Ltd
Subscribe to Newsletter